food and drug administration, Compound and weight loss

Millions of people are taking compounded weight loss drugs. Now they're about to disappear.
Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now soon they may be unavailable to most.
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.
The FDA Cracking Down on Compounded Weight Loss Drugs – Here’s What It Means for Telehealth Companies and Consumers
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they will be prohibiting like-for-like compounded versions.
These discounted versions of popular weight-loss drugs are going away: What to know
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight loss medications for people who are obese or who are overweight and have one weight-related health condition,
FBI issues safety warning about counterfeit versions of weight loss drug semaglutide
Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is also approved to reduce the risk of major cardiovascular events in adults with obesity or who are overweight with established cardiovascular disease.
Who can get weight loss drugs on the NHS in Scotland?
The medicines watchdog has agreed the drugs are safe and cost-effective for NHS use. Last year, semaglutide was approved for treating obesity under the brand name Wegovy. It has also been licensed under the brand name Ozempic for treating diabetes in some circumstances,
Compound versions of weight loss drugs will no longer be available, FDA rules
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available after a decision by the U.S. Food and Drug Administration. The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply.
Medications For Weight Loss
Dr. Alexandro Zarruk, MD, MSc., FACP, FRCPC, Internal Medicine, talks about medications that can help patients lose weight.
Florida Politics2d
Mark Baughman: The hidden dangers of compounded medicines — a call for caution
These medications are not FDA-approved, meaning they do not undergo the rigorous testing for safety, effectiveness, and ...
Medscape1d
The End of Compounded GLP-1s: What Physicians Need to Know
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
Rolling Out16h
8 natural nootropics that rival synthetic smart drugs
Research shows how specific natural nootropics can enhance memory, focus, and cognitive processing while potentially offering ...
News-Medical.Net on MSN4d
Compound found in rosemary shows promise for Alzheimer's treatment
The herb rosemary has long been linked with memory: "There's rosemary, that's for remembrance," says Ophelia in Shakespeare's ...
EurekAlert!2d
Improving rehabilitation after spinal cord injury using a small compound oral drug
Spinal cord injury (SCI) resulting in severe paralysis is known to deteriorate the quality of life of humans. However, the ...